[go: up one dir, main page]

Trocme et al., 1994 - Google Patents

Eosinophil granule major basic protein inhibition of corneal epithelial wound healing.

Trocme et al., 1994

View PDF
Document ID
14718912020599229525
Author
Trocme S
Gleich G
Kephart G
Zieske J
Publication year
Publication venue
Investigative ophthalmology & visual science

External Links

Snippet

PURPOSE: Human eosinophil major basic protein (MBP) was studied in an established organ culture model for rat corneal epithelial wound healing to elucidate further the role of the protein in vernal keratopathy. METHODS: Epithelial migration rates were tested for five …
Continue reading at iovs.arvojournals.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Trocme et al. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing.
Nishida et al. Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo
Wilson Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis
Nakamura et al. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo
Wuest et al. VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis
Babizhayev et al. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma
Talamo et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids
Trocmé et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis
Jejurikar et al. Skeletal muscle denervation increases satellite cell susceptibility to apoptosis
Sotozono et al. Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo.
Hoppenreijs et al. Effects of human epidermal growth factor on endothelial wound healing of human corneas.
Tervo et al. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation
EP0735895B1 (en) A method for preventing or controlling cataract
Stepp et al. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury.
US20090062187A1 (en) Use of Hmgb1 for Wound Healing
KR20170132197A (en) Ophthalmic compositions and methods of use thereof
NAKAMURA et al. Fibronectin facilitates corneal epithelial wound healing in diabetic rats
US7282482B2 (en) NGF for the prevention of demyelination in the nervous system
Messmer et al. Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis
US20240277797A1 (en) Method for treating or preventing neovascular eye disease
Watanabe et al. Chemotactic and haptotactic activities of fibronectin for cultured rabbit corneal epithelial cells.
Beuerman et al. Molecular and cellular responses of the corneal epithelium to wound healing
Burke et al. Retinal pigment epithelial cells of the posterior pole have fewer Na/K adenosine triphosphatase pumps than peripheral cells.
Wang et al. Enhancement of fibronectin-induced migration of corneal epithelial cells by cytokines.
Nanney et al. CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism